%A WANG Meng-Sen, YU Yong-Hua %T Progress of prevention and cure of chemoradiotherapy-related hepatitis B virus reactivation %0 Journal Article %D 2014 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2014.03.007 %P 184-187 %V 41 %N 3 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_9325.shtml} %8 2014-03-08 %X Reactivation of hepatitis B virus (HBV) in cancer patients with HBV infection during or after chemoradiotherapy can lead to acute liver injury, even death. Antiviral prophylaxis can reduce the occurrence of HBV reactivation and its associated morbidity. However, there is no unified standard to guide antiviral treatment. Therefore, multidisciplinary collaboration and more prospective study should be carried out to identify the individual antiviral treatment plan.